Directors
Dr Charmaine Gittleson (Chair)
Dr Gil Price
Dr James Garner
Auditors
William Buck Audit (Vic) Pty Ltd
Level 20, 181 William Street,
Melbourne, Victoria, 3000
Solicitors
Minter Ellison
Collins Arch, 447 Collins Street,
Melbourne, Victoria, 3000
Company Secretary
Ms Deborah Ambrosini
Company
Percheron Therapeutics Limited
ACN 095 060 745
Share Register
Boardroom Pty Limited
Level 8, 210 George Street,
Sydney, NSW 2000
1300 737 760 (within Australia)
+61 2 9290 9600 (international)
Registered Office
L30, Collins Place
35 Collins Street
Melbourne, VIC 3000
Australia
Australian Stock Exchange
Percheron Therapeutics Limited shares are quoted on the Australian Stock Exchange.
ASX Code: PER
Principal Administrative Office & Mailing Address
L30, Collins Place
35 Collins Street
Melbourne, VIC 3000
Australia
+61 3 9827 8999
Facsimile: +61 3 9859 7701
OTCQB Venture Market Information
Percheron Therapeutics Limited (OTCQB: PERCF) trades on the OTCQB Venture Market.
Symbol: PERCF
Market: OTCQB
CUSIP: Q04007128
Country: Australia
Effective Date: November 29, 2024
Bankers
Commonwealth Bank of Australia
Melbourne, Victoria